Skip to main content

Table 6 Correlation analysis of proteolytic enzymes, CEA and CA 19-9 in colorectal cancer.

From: Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer

 

Colorectal cancer

 

Pvalue

(correlation coefficient)

CATB/CATL

P = 0.0001

(rS = 0.67)

CATB/uPA

P = 0.03

(rS = 0.28)

CATB/PAI-1

P = 0.04

(rS = 0.27)

CATL/uPA

P = 0.11

(rS = 0.21)

PAI-1/CATL

P = 0.03

(rS = 0.27)

PAI-1/uPA

P = 0.001

(rS = 0.41)

CEA/CA 19-9

P = 0.0003

(rS = 0.46)

CEA/CATB

P = 0.002

(rS = 0.40)

CEA/CATL

P = 0.06

(rS = 0.25)

CEA/uPA

P = 0.70

(rS = 0.05)

CEA/PAI-1

P = 0.002

(rS = 0.40)

CA 19-9/CATB

P = 0.005

(rS = 0.36)

CA 19-9/CATL

P = 0.33

(rS = 0.13)

CA 19-9/uPA

P = 0.46

(rS = 0.10)

CA 19-9/PAI-1

P = 0.005

(rS = 0.36)

  1. Correlation of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in patients with colorectal cancer (n = 56)
  2. Abbreviations: CATB: cathepsin B; CATL: cathepsin L; uPA: urokinase-type plasminogen activator, PAI-1: plasminogen activator inhibitor type-1; CEA: carcinoembryonic antigen; CA 19-9: carbohydrate antigen 19-9; rS: Spearman rank correlation coefficient